4 completed, 1 recruiting, 1 withdrawn. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Olfactory Disorder: new trials by email Literature Review of Olfactory Disorder trials Research Report on Olfactory Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID) Trigeminal Nerve Stimulation (TNS), Active Smell Training (ST), Placebo Smell Training (PBO) - Smell Dysfunction, Olfactory Disorder | Phase 2 / Phase 3 | Recruiting | Medical University of South Carolina | 145 | 2023-10-02 | 2026-04-02 |
| Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Stellate Ganglion Block - Anosmia, Hyposmia | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 20 | 2022-09-01 | 2026-02-12 |
| Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction Gabapentin gelatin capsules 300mg, Placebo - COVID-19, Olfactory Disorder | Phase 2 | Completed | Washington University School of Medicine | 68 | 2022-01-10 | 2025-03-04 |
| Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia Fluvoxamine, Placebo - COVID-19, Olfactory Disorder | Phase 2 | Withdrawn | Washington University School of Medicine | 2021-12-14 | 2022-03-11 | |
| Smell in Covid-19 and Efficacy of Nasal Theophylline Theophylline Powder, Placebo Comparator - Covid19, Anosmia | Phase 2 | Completed | Washington University School of Medicine | 51 | 2021-03-15 | 2023-05-24 |
| Smell Changes & Efficacy of Nasal Theophylline Theophylline, Saline Nasal - Olfactory Disorder, Anosmia | Phase 2 | Completed | Washington University School of Medicine | 27 | 2019-05-15 | 2022-03-31 |
Olfaction Disorders (6) · Anosmia (5) · COVID-19 (5) · Ageusia (1) · Post-Acute COVID-19 Syndrome (1) · Virus Diseases (1)
Infections (6) · Nervous System Diseases (6) · Neurologic Manifestations (6) · Pathological Conditions, Signs and Symptoms (6) · Sensation Disorders (6) · Signs and Symptoms (6) · Coronaviridae Infections (5) · Coronavirus Infections (5) · Lung Diseases (5) · Nidovirales Infections (5) · Pneumonia (5) · Pneumonia, Viral (5) · RNA Virus Infections (5) · Respiratory Tract Diseases (5) · Respiratory Tract Infections (5)
Fluvoxamine (1) · Mepivacaine (1) · Olfactory Training (1) · Sodium Chloride (1) · Theophylline (1) · Transcutaneous Electric Nerve Stimulation (1)
Washington University School of Medicine (5) · Medical University of South Carolina (1)
United States (6)
Jay F Piccirillo, MD (2) · Jay F Piccirillo, M.D., FACS (1)
R01DC021179 (1)